Literature DB >> 301553

Immunostimulators induce granulocyte/macrophage colony-stimulating activity and block proliferation in a monocyte tumor cell line.

P Ralph, H E Broxmeyer, I Nakoinz.   

Abstract

Monocyte tumor cell line PU5-1.8 does not normally produce colony-stimulating activity (CSA) required by granulocyte and macrophage progenitors to proliferate and mature in agar. However, CSA is induced in the culture line by as little as 10 ng/ml endotoxic lipopolysaccharide (LPS), with maximum CSA production and release to the medium between 2 and 3 days of incubation. Derived lipid A, but not alkali-treated LPS, is also active. Induction requires RNA and protein synthesis, but is not blocked by mitomycin C or Colcemid. Other inducers of CSA include Mycobacterium Bacillus Calmette-Guérin, tuberculin protein preparation purified protein derivative, zymosan, and phorbol myristate. All inducing agents are specific inhibitors of the monocyte tumor cell proliferation in vitro. Latex beads, another macrophage-activating agent, are rapidly phagocytosed by PU5-1.8 cells, but neither inhibit growth nor induce CSA.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301553      PMCID: PMC2180775          DOI: 10.1084/jem.146.2.611

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Stimulation by dimethyl sulfoxide of erythroid differentiation and hemoglobin synthesis in murine virus-induced leukemic cells.

Authors:  C Friend; W Scher
Journal:  Ann N Y Acad Sci       Date:  1975-01-27       Impact factor: 5.691

2.  Lymphosarcoma cell growth is selectively inhibited by B lymphocyte mitogens: LPS, dextran sulfate and PPD.

Authors:  P Ralph; I Nakoinz; W C Raschke
Journal:  Biochem Biophys Res Commun       Date:  1974-12-23       Impact factor: 3.575

3.  Effect of endotoxin on the production of colony-stimulating factor by human monocytes and macrophages.

Authors:  M J Cline; B Rothman; D W Golde
Journal:  J Cell Physiol       Date:  1974-10       Impact factor: 6.384

4.  In vitro colony formation by normal and leukemic human hematopoietic cells: interaction between colony-forming and colony-stimulating cells.

Authors:  M A Moore; N Williams; D Metcalf
Journal:  J Natl Cancer Inst       Date:  1973-03       Impact factor: 13.506

5.  In vitro production of colony-stimulating activity. I. Exposure of mouse peritoneal cells to endotoxin.

Authors:  A C Eaves; W R Bruce
Journal:  Cell Tissue Kinet       Date:  1974-01

6.  Release of colony-stimulating factor from monocytes by endotoxin and polyinosinic-polycytidylic acid.

Authors:  F W Ruscetti; P A Chervenick
Journal:  J Lab Clin Med       Date:  1974-01

7.  Cytotoxic activity of lymphocytes. V. Role of soluble toxin in macrophage-inhibited cultures of tumor cells.

Authors:  W P Reed; Z J Lucas
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

8.  Lipid A, the active part of bacterial endotoxins in inducing serum colony stimulating activity and proliferation of splenic granulocyte/macrophage progenitor cells.

Authors:  R N Apte; C Galanos; D H Pluznik
Journal:  J Cell Physiol       Date:  1976-01       Impact factor: 6.384

9.  Direct toxic effects of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture.

Authors:  P Ralph; I Nakoinz
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

10.  Human blood monocytes: stimulators of granulocyte and mononuclear colony formation in vitro.

Authors:  P A Chervenick; A F LoBuglio
Journal:  Science       Date:  1972-10-13       Impact factor: 47.728

View more
  11 in total

1.  Granulocyte-macrophage colony-stimulating factor elevates invariant chain expression in immature myelomonocytic cell lines.

Authors:  I Klagge; U Kopp; N Koch
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

2.  Augmented production of colony-stimulating factor in C3H/HeN mice immunized with Nocardia rubra cell wall skeleton.

Authors:  S Hayashi; T Masuno; S Hosoe; I Kawase; M Sakatani; T Ogura; S Kishimoto; Y Yamamura
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

3.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

4.  In vitro and in vivo anti-inflammatory activity of 17-O-acetylacuminolide through the inhibition of cytokines, NF-κB translocation and IKKβ activity.

Authors:  Mouna Achoui; David Appleton; Mahmood Ameen Abdulla; Khalijah Awang; Mustafa Ali Mohd; Mohd Rais Mustafa
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

5.  Tumor promoter phorbol myristic acetate stimulates immunoglobulin secretion correlated with growth cessation in human B lymphocyte cell lines.

Authors:  P Ralph; T Kishimoto
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

6.  Prostaglandin regulation of colony-stimulating factor production by lipopolysaccharide-stimulated murine leukocytes.

Authors:  R N Moore; R Urbaschek; L M Wahl; S E Mergenhagen
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

7.  Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.

Authors:  W D Xu; G S Firestein; R Taetle; K Kaushansky; N J Zvaifler
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

8.  Induction of tumor necrosis factor by Legionella pneumophila.

Authors:  D K Blanchard; J Y Djeu; T W Klein; H Friedman; W E Stewart
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

9.  Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Lorenzo Galluzzi; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

10.  Induction of granulocyte-macrophage colony-stimulating activity in mouse skin by inflammatory agents and tumor promoters.

Authors:  M J Koury; A Balmain; I B Pragnell
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.